Allodynia
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Asymmetric Diabetic Proximal Motor Neuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome.
|
16289943 |
2006 |
Complex Partial Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
Cryptogenic Tonic-Clonic Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Diabetic Amyotrophy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Asymmetric Polyneuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Autonomic Neuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Mononeuropathy
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Neuralgia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Neuropathies
|
0.310 |
Therapeutic
|
group |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Diabetic Polyneuropathies
|
0.300 |
Therapeutic
|
group |
CTD_human |
Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies.
|
11779407 |
2001 |
Down Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome.
|
16289943 |
2006 |
Down Syndrome, Partial Trisomy 21
|
0.300 |
Biomarker
|
disease |
CTD_human |
Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome.
|
16289943 |
2006 |
Epilepsy, Tonic-Clonic, Familial
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Epilepsy, Tonic-Clonic, Symptomatic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Tonic-clonic seizures induce division of neuronal progenitor cells with concomitant changes in expression of neurotrophic factors in the brain of pilocarpine-treated mice.
|
16023256 |
2005 |
Grand Mal Status Epilepticus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
|
8635431 |
1996 |
hearing impairment
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
[Protective effect of adeno-associated virus-mediated neurotrophin-3 on the cochlea of guinea pigs with gentamicin-induced hearing loss].
|
18024279 |
2007 |
Hyperalgesia
|
0.310 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Hyperalgesia, Primary
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Hyperalgesia, Secondary
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Hyperalgesia, Thermal
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Continuous infusion is required for suppression of both thermal hyperalgesia and TRPV1 expression, because removal of NT-3 resulted in a prompt reestablishment of the hyperalgesic state and corresponding CCI-associated TRPV1 phenotype.
|
15659614 |
2005 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that the changes in the expression levels of GDNF, ARTN, and NT-3 mRNAs might be state-dependent and associated with the pathophysiology of major depression.
|
18313696 |
2008 |
Mechanical Allodynia
|
0.310 |
Therapeutic
|
phenotype |
CTD_human |
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons.
|
15659614 |
2005 |
Mood Disorders
|
0.320 |
Biomarker
|
group |
PSYGENET |
The gene for neurotrophic tyrosine kinase receptor 3 (NTRK3), the receptor for neurotrophin-3 (trkC) and a key gene in neurotrophin signaling, is located within this region and, given evidence for synaptic plasticity as a mechanism in mood disorders, was considered a prime candidate.
|
18347002 |
2008 |